Is Intensity Therapeutics, Inc. (INTS) a Buy, Sell, or Hold?
NASDAQ : INTS
Intensity Therapeutics, Inc. — Competitors
$4.16 USD
-$0.09 (-2.13%)
- Volume
- 22.34K
- Average Volume
- 40.36K
- Market Capitalization
- $11.24M
- P/E Ratio
- -0.60
- Dividend Yield
- 0.00%
- Price Target
- $125.00
- Year High
- $43.50
- Year Low
- $3.51
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.86
INTS vs. The Competition
| Properties | INTS | ANTX | BOLD | IBIO |
|---|---|---|---|---|
| Market Cap | $11.24M | $213.58M | $64.95M | $22.26M |
| Shares Outstanding | $2.7M | $36.02M | $22.47M | $15.79M |
| P/E Ratio | -0.6 | -5.39 | -1.01 | -2.45 |
| EPS | -0.42 | -1.01 | -2.85 | -0.23 |
| Day Low | 4.16 | 5.775 | 2.725 | 1.375 |
| Day High | 4.5304 | 6.17 | 2.89 | 1.425 |
| Year Low | 3.51 | 1 | 0.961 | 0.57 |
| Year High | 43.5 | 6.91 | 2.92 | 3.82 |
| Average Price 50 | 4.2595 | 4.794 | 2.1567 | 1.5818 |
| Average Price 200 | 7.30603 | 2.91831 | 1.48443 | 1.8363 |
| Volume | 22345 | 121.61K | 940.36K | 435.93K |
| Average Volume | - | - | - | - |